Key Insights

Highlights

Treatment Research

3 treatments under study, led by Standard Oxygenation

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2/3 (1)

Trial Status

Unknown2

Clinical Trials (2)

Showing 2 of 2 trials
NCT03282331Not ApplicableUnknown

Lung MORphological Modifications Evaluated by Electrical Impedance Tomography During Preoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation (MORPHEIT Study, an Ancillary Study of PREONIV Trial)

NCT01782430Phase 2/3Unknown

PREoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation

Showing all 2 trials

Research Network

Common Treatments

  • Standard Oxygenation2
  • High Flow Nasal Oxygenation1
  • Noninvasive Ventilation1

Active Sponsors

  • University Hospital, Clermont-Ferrand2
  • Hopital Gabriel Montpied1

Top Investigators

Related Conditions

  • Patient Covered By French Health Care System2
  • Requiring Intubation2
  • Adult Patients2

Activity Timeline